HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 283 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $91,733,000 | -38.1% | 1,482,200 | -20.2% | 1.86% | -45.1% |
| Q2 2022 | $148,106,000 | +24.4% | 1,856,900 | +64.1% | 3.40% | +37.2% |
| Q1 2022 | $119,035,000 | +9.2% | 1,131,400 | +11.8% | 2.48% | +7.2% |
| Q4 2021 | $109,053,000 | +20.5% | 1,012,000 | +22.5% | 2.31% | +15.4% |
| Q3 2021 | $90,480,000 | +70.1% | 826,000 | +45.4% | 2.00% | +39.4% |
| Q2 2021 | $53,188,000 | -0.5% | 568,000 | -2.2% | 1.44% | -2.6% |
| Q1 2021 | $53,475,000 | -37.5% | 581,000 | -50.3% | 1.48% | -46.8% |
| Q4 2020 | $85,534,000 | +18.4% | 1,169,300 | +25.7% | 2.78% | -17.2% |
| Q3 2020 | $72,258,000 | +142.5% | 930,200 | +73.5% | 3.35% | +75.5% |
| Q2 2020 | $29,802,000 | +202.2% | 536,200 | +61.0% | 1.91% | +40.1% |
| Q1 2020 | $9,863,000 | +81.6% | 333,000 | +122.0% | 1.36% | -60.2% |
| Q4 2019 | $5,430,000 | – | 150,000 | – | 3.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |